Acurx Pharmaceuticals, Inc. Selling, General and Administrative Expense
Acurx Pharmaceuticals, Inc. (ACXP) reported Selling, General and Administrative Expense of $0 for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2022-08-12
- Acurx Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2022-06-30 was $0.00.
- Acurx Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2022-03-31 was $113.10K.
- Acurx Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2021-12-31 was $0.00.
- Acurx Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2021 was $208.27K.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | $113.10K 10-Q · filed 2022-08-12 | $113.10K derived: sum of 3 quarters · filed 2022-08-12 | |
| 2022-03-31 | $113.10K 10-Q · filed 2022-05-10 | $113.10K derived: sum of 2 quarters · filed 2022-05-10 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $208.27K 10-K · filed 2022-03-16 | ||
| 2021-09-30 | $208.27K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |